Ketty Shkolnik

Ketty Shkolnik, PhD, is a Clinical and Regulatory Affairs expert with over 14 years of experience supporting medical device companies in clinical and regulatory programs. Currently serving as the Chief Clinical and Regulatory Officer at NINA Medical, Ketty leads the transition to clinical phases, including First-in-Human studies. Previously, Ketty held significant roles, including Senior Director of Clinical Affairs at NUVO Group and Head of Pre-Clinical and Clinical Research at Syneron Candela. Ketty co-founded Minovia Therapeutics and managed pre-clinical development, demonstrating strong leadership and strategic capabilities in diverse healthcare settings. Ketty earned a Ph.D. in Reproductive Endocrinology/Molecular Biology from the Weizmann Institute of Science.